Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-κB signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 2, 2009, Pages

  Zou, Luyun ^a   Yang, Shaolong ^b   Champattanachai, Voraratt ^a   Hu, Shunhua ^b   Chaudry, Irshad H ^b   Marchase, Richard B ^a   Chatham, John C ^a,c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cytokines; Neonatal rat ventricular myocytes; Nuclear factor B; O Linked N acetylglucosamine

Indexed keywords

GLUCOSAMINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; O LINKED N ACETYLGLUCOSAMINE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; O GLCNAC TRANSFERASE; O-GLCNAC TRANSFERASE; PEROXIDASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ATTENUATION; BLEEDING; CELL ACTIVATION; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GENETIC TRANSFECTION; HEART FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; INJURY; MACROPHAGE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RESUSCITATION; ACYLATION; ANIMAL; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; HEART CONTRACTION; HEMODYNAMICS; HEMORRHAGIC SHOCK; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACETYLGLUCOSAMINE; ACYLATION; ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLUCOSAMINE; HEMODYNAMICS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; N-ACETYLGLUCOSAMINYLTRANSFERASES; NF-KAPPA B; PEROXIDASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SHOCK, HEMORRHAGIC; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61949134041     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01025.2008     Document Type: Article

References (53)

1. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Holl- ingsworth-Fridlund P, Hoyt DB. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 186: 528-533, 1998.
2. Alam HB, Koustova E, Rhee P. Combat casualty care research: from bench to the battlefield. World J Surg 29, Suppl 1: S7-S11, 2005.
3. Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock 14: 81-90, 2000.
4. Barringer ML, Thomason MH, Kilgo P, Spallone L. Improving outcomes in a regional trauma system: impact of a level III trauma center. Am J Surg 192: 685-689, 2006.
5. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294: C1509-C1520, 2008.
6. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 294: C1509-C1520, 2008.
7. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 292: C178-C187, 2007.
8. Chatham JC, Not LG, Fulop N, Marchase RB. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma. Shock 29: 431-440, 2008.
9. Chou TY, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-18965, 1995.
10. Choudhry MA, Schwacha MG, Hubbard WJ, Kerby JD, Rue LW, Bland KI, Chaudry IH. Gender differences in acute response to trauma- hemorrhage. Shock 24, Suppl 1: 101-106, 2005.
11. Copeland RJ, Bullen JW, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 295: E17-E28, 2008.
12. Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 14: 162-169, 2001.
13. Fulop N, Marchase RB, Chatham JC. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res 73: 288 -297, 2007.
14. Fulop N, Zhang Z, Marchase RB, Chatham JC. Glucosamine cardio- protection in perfused rat heart associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Am J Physiol Heart Circ Physiol 292: H2227-H2236, 2007.
15. Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 236: 302-308, 2001.
16. Hunton DL, Lucchesi PA, Pang Y, Cheng X, Dell'Italia LJ, Marchase RB. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem 277: 14266-14273, 2002.
17. Hunton DL, Zou LY, Pang Y, Marchase RB. Adult rat cardiomyocytes exhibit capacitative calcium entry. Am J Physiol Heart Circ Physiol 286: H1124-H1132, 2004.
18. James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, Scholey JW. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes 51: 1146-1156, 2002.
19. Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, Hart GW, Marban E. Cardioprotection by A-acetylglucosamine linkage to cellular proteins. Circulation 117: 1172-1182, 2008.
20. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96: 1042-1052, 1995.
21. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 36: 691-709, 2005.
22. Liang Y, Zhou Y, Shen P. NF-kappaB and its regulation on the immune system. Cell Mol Immunol 1: 343-350, 2004.
23. Liu J, Marchase RB, Chatham JC. Increased O-GlcNAc levels during reperfusion leads to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol 293: H1391-H1399, 2007.
24. Liu J, Pang Y, Chang T, Bounelis P, Chatham JC, Marchase RB. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol 40: 303-312, 2006.
25. Liu SF, Malik AB. NF-kB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645, 2006.
26. Love DC, Hanover JA. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005: re13, 2005.
27. Macauley MS, Whitworth GE, Debowski AW, Chin D, Vocadlo DJ. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280: 25313-25322, 2005.
28. Masson E, Wiernsperger N, Lagarde M, El Bawab S. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 388: 537-544, 2005.
29. McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C. Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 15: 171-186, 2001.
30. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol Regul Integr Comp Physiol 274: R577-R595, 1998.
31. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol 29: 2849-2854, 1997.
32. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214, 2006.
33. National Heart, Lung, and Blood Institute. Hypovolemic circulatory collapse: mechanisms to improve resuscitation outcomes. RFA No. HL-03-015, 2003.
34. Not LG, Brocks CA, Marchase RB, Chatham JC. O-GlcNAc agonist treatment improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats (Abstract). FASEB J 22: 1227, 2008.
35. Pang Y, Hunton DL, Bounelis P, Marchase RB. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 51: 3461-3467, 2002.
36. Peng R, Chang C, Gilmore D, Bongard F. Epidemiology of immediate and early trauma deaths at an urban level I trauma center. Am Surg 64: 950-954, 1998.
37. Perreira M, Kim EJ, Thomas CJ, Hanover JA. Inhibition of O- GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry. Bioorg Med Chem 14: 837-846, 2006.
38. Regel G, Grotz M, Weltner T, Sturm JA, Tscherne H. Pattern of organ failure following severe trauma. World J Surg 20: 422-429, 1996.
39. Sampalis JS, Denis R, Lavoie A, Frechette P, Boukas S, Nikolis A, Benoit D, Fleiszer D, Brown R, Churchill-Smith M, Mulder D. Trauma care regionalization: a process-outcome evaluation. J Trauma 46: 565-579, 1999.
40. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 38: 185-193, 1995.
41. Schneider CP, Nickel EA, Samy TS, Schwacha MG, Cioffi WG, Bland KI, Chaudry IH. The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis. Shock 14: 347-353, 2000.
42. Shaw P, Freeman J, Bovey R, Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12: 921-930, 1996.
43. Slawson C, Housley MP, Hart GW. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem 97: 71-83, 2006.
44. Stanley P. A method to the madness of W-glycan complexity? Cell 129: 27-29, 2007.
45. Ulvik A, Wentzel-Larsen T, Flaatten H. Trauma patients in the intensive care unit: short- and long-term survival and predictors of 30-day mortality. Acta Anaesthesiol Scand 51: 171-177, 2007.
46. Wells L, Whalen SA, Hart GW. O-GlcNAc: a regulatory post- translational modification. Biochem Biophys Res Commun 302: 435-441, 2003.
47. Xing D, Feng W, Not LG, Miller AP, Zhang Y, Chen YF, Majid-Hassan E, Chatham JC, Oparil S. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endolu- minal arterial injury. Am J Physiol Heart Circ Physiol 295: H335-H342, 2008.
48. Yang S, Zheng R, Hu S, Ma Y, Choudhry MA, Messina JL, Rue LW 3rd, Bland KI, Chaudry IH. Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function. Am J Physiol Heart Circ Physiol 287: H2183-H2191, 2004.
49. Yang S, Zou LY, Bounelis P, Chaudry I, Chatham JC, Marchase RB. Glucosamine administration during resuscitation improves organ function after trauma hemorrhage. Shock 25: 600-607, 2006.
50. Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673: 13-28, 2004.
51. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279: 30133-30142, 2004.
52. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. O- GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115: 715-725, 2003.
53. Zou LY, Yang S, Chaudry IH, Marchase RB, Chatham JC. PUGNAc administration during resuscitation improves organ function following trauma-hemorrhage. Shock 27: 402-408, 2007.